Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Announcement under Regulation 30 (LODR)-Retirement

 This is to inform that the Board of Directors at its Meeting held today i.e., May 30, 2023 noted the retirement of Mr. Rajesh Marwaha (DIN: 01458768) from the Office of Chief Financial Officer and Whole-time Director of the Company with effect from the closing of business hours on September 30, 2023. While taking note of the same, the Board has placed on record its sincere thanks and appreciation for his contribution during his tenure in the Company.
30-05-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Regulation 23(9) - Related Party Transactions For The Half-Year Ended 31 March 2023

 Pursuant to the provisions of Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we enclose herewith the disclosure of Related Party Transactions for half year ended March 31, 2023 for your information and records.
30-05-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Outcome Of The Board Meeting Held On Tuesday, May 30, 2023

 The Board of Directors of the Company at its Meeting held today i.e., May 30, 2023, has inter-alia: 1. Approved the Audited Financial Results of the Company for the quarter and year ended March 31, 2023. The said Audited Financial Results together with the Audit report of the Statutory Auditors dated May 30, 2023 are enclosed herewith. 2. Recommended Dividend of Rs. 16/- per equity share for the Financial Year 2022-23. We also confirm that the Statutory Auditor's Report is with unmodified opinion in respect of the Audited Financial Results of the Company for the Financial Year ended March 31, 2023. The Board Meeting concluded at 4:30 p.m. Please take the same on record.
30-05-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, May 30, 2023

 The Board of Directors of the Company at its Meeting held today i.e., May 30, 2023, has inter-alia: 1. Approved the Audited Financial Results of the Company for the quarter and year ended March 31, 2023. The said Audited Financial Results together with the Audit report of the Statutory Auditors dated May 30, 2023 are enclosed herewith. 2. Recommended Dividend of Rs. 16/- per equity share for the Financial Year 2022-23. We also confirm that the Statutory Auditor's Report is with unmodified opinion in respect of the Audited Financial Results of the Company for the Financial Year ended March 31, 2023. The Board Meeting concluded at 4:30 p.m. Please take the same on record.
30-05-2023
Bigul

Annual report for AstraZeneca Pharma India Ltd. for FY-2023
30-05-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 In terms of SEBI's Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, we furnish herewith the Secretarial Compliance Report, for the year ended March 31, 2023. Please take the same on record.
26-05-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agents of the Company, Integrated Registry Management Services Private Limited have informed the Company on the enclosed request for Loss of Share Certificate from the claimant.
25-05-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Tuesday, May 30, 2023

 ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve 1. The Audited Financial Results of the Company for the quarter and year ended March 31, 2023; and 2. To recommend Dividend, if any, on the Equity Shares of the Company for the Financial Year 2022-23.
22-05-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agents of the Company, Integrated Registry Management Services Private Limited have informed the Company on the enclosed request for Loss of Share Certificate from the legal representative of the claimant.
15-05-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We are enclosing herewith the Certificate dated May 5, 2023 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Please take the same on record.
08-05-2023
Next Page
Close

Let's Open Free Demat Account